Company intelligence / Profile preview

Foundation for Sickle Cell Disease Research

Hollywood, Florida, United States

Ownership: Private
Development stage: Other

Overview

The Foundation for Sickle Cell Disease Research (FSCDR) operates the largest network of outpatient care centers in the U.S. dedicated exclusively to sickle cell disease, conducting innovative clinical research, providing comprehensive care services, and advancing education and advocacy. They support both research and clinical programs, but there is no single drug or therapy program; instead, they focus on improving standards of care and quality of life for individuals with sickle cell disease through multidisciplinary approaches.[3][5][7][9][10]

Therapeutic areas: Hematology
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Foundation for Sickle Cell Disease Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foundation for Sickle Cell Disease Research.

Explore the full profile